The authors provide their perspectives on shipping validation.
An exponential feeding strategy coupled with automation doubled protein yields while reducing fermentation time by 25%.
ACF medium sped up cell-line development.
An exponential feeding strategy coupled with automation doubled protein yields while reducing fermentation time by 25%.
HTPD allows rapid screening of chromatographic parameters.
Low-pressure process chromatography could not have developed without immense efforts to resolve scale-up issues in both column design and matrix stability.
Collaborations between Western and Indian companies may provide the best path for offshoring successfully and for developing India's readiness.
New technologies and adaptations of existing technologies can improve platform processes.
This alternative to column chromatography is suitable for flow-through as well as bind-and-elute purification operations.
Release testing involves both standard potency assays and unique assays (particle size, NA activity) developed to ensure the physical, chemical, and biological stability of this type of vaccine.
A case study implementing rapid microbiological methods.
ACF medium sped up cell-line development.
STIC allows polishing to be carried out without an interstitial dilution step, which reduces process time and avoids additional buffer preparation and hold steps.
Needle-free vaccine delivery platforms can solve the problems of stockpiling, cold-chain management, and pandemic preparedness.
Release testing involves both standard potency assays and unique assays (particle size, NA activity) developed to ensure the physical, chemical, and biological stability of this type of vaccine.
This article presents ongoing research at VIDO-InterVac for the development of safer and more effective adjuvants. These include adjuvants that stimulate innate immunity in the body and combination adjuvants.
In this question-and-answer discussion of "generic" biologics, the authors contend small changes in manufacturing of biologics dramatically affect the safety and efficacy of the therapeutic molecule.
A step-by-step approach is essential for successful implementation.
Clinical studies have shown that treatment with thymosin alpha 1 increases response to vaccination.
Wet testing of microbial fermenters allows for a greater understanding of the equipment's capabilities.
By considering stability as part of the cell line selection and cell banking paradigm, we can ensure that instability problems are not observed during clinical or commercial manufacturing.
New technologies and adaptations of existing technologies can improve platform processes.
A systematic approach facilitates formulation component selection.
Best methods to maximize product yield and membrane lifetime to enhance a tangential flow filtration process.
How to successfully balance patient safety with supply-chain management
Engaging executive leadership in the quality process is the key to compliance success.
Robust packing procedures can improve process performance and increase resin lifetime.